Detalhe da pesquisa
1.
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas.
Blood
; 127(7): 858-68, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603836
2.
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
Blood
; 127(2): 221-32, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26463425
3.
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice.
J Transl Med
; 11: 120, 2013 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23663506
4.
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms.
Oncoimmunology
; 7(4): e1341032, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632712
5.
CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
Mol Cancer Ther
; 11(3): 670-9, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203728
6.
Anaplastic lymphoma kinase in human cancer.
J Mol Endocrinol
; 47(1): R11-23, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21502284